Quick Comparison

BakuchiolTretinoin
Typical ConcentrationConcentrations: 0.5%-2%. Can be used morning and/or night (not photosensitizing like retinoids). Apply after cleansing. Can be combined with retinoids for enhanced effects. Safe to use without SPF specifically for this ingredient, though daily SPF is always recommended.Concentrations: 0.025%, 0.05%, 0.1%. Start with 0.025% every other night for 4-6 weeks, then increase frequency. Apply pea-sized amount to dry face 20 minutes after cleansing. Always use with SPF 30+ during the day. Retinization period: 4-12 weeks of initial irritation.
ApplicationTopical (serum, oil, cream). Stable in formulation. Not photosensitizing.Topical (cream, gel, microsphere). Apply to clean, dry skin at night. Microsphere formulations (Retin-A Micro) release tretinoin slowly, reducing irritation.
Research Papers10 papers10 papers
Categories

Mechanism of Action

Bakuchiol

Bakuchiol (meroterpene from Psoralea corylifolia) achieves retinol-like effects through RAR/RXR-independent pathways. It upregulates collagen I and III in fibroblasts via TGF-beta/Smad signaling and possibly ER-beta cross-talk. Bakuchiol downregulates MMP-1, preserving dermal collagen. It accelerates keratinocyte differentiation and stratum corneum turnover through distinct pathways. Direct antioxidant activity scavenges ROS and inhibits lipid peroxidation. Anti-inflammatory effects may involve NF-kappaB modulation. Clinical studies show comparable wrinkle reduction to 0.5% retinol; combination with retinol shows synergy. Safe during pregnancy—does not activate retinoic acid receptors.

Tretinoin

Tretinoin binds nuclear retinoic acid receptors (RAR-alpha, beta, gamma), forming RAR/RXR heterodimers that bind retinoic acid response elements and activate gene transcription. This accelerates keratinocyte proliferation, reducing stratum corneum transit from ~28 to ~14 days. In the dermis, tretinoin stimulates fibroblasts and upregulates collagen I and III via TGF-beta while downregulating MMP-1, MMP-3, and MMP-9 that degrade the extracellular matrix. It normalizes melanocyte distribution and melanosome transfer. In acne, it prevents microcomedo formation by normalizing follicular keratinocyte differentiation and reducing corneocyte cohesion. RAR activation also modulates genes for epidermal growth factors and differentiation markers.

Risks & Safety

Bakuchiol

Common

Very few — bakuchiol is exceptionally well-tolerated. Mild tingling in some users initially.

Serious

None documented. Safe during pregnancy.

Rare

Allergic reaction (rare plant allergy).

Tretinoin

Common

Dryness, peeling, redness, increased sun sensitivity (mandatory SPF). Initial purging (breakouts) for 4-8 weeks.

Serious

Teratogenic — absolutely contraindicated in pregnancy and breastfeeding.

Rare

Severe irritant contact dermatitis, eczema flare-ups.

Full Profiles